North China Pharmaceutical’s subsidiary’s VC anti-monopoly case draws public attention
Summary: North China Pharmaceutical has recently updated the public on the VC anti-monopoly case of its subsidiary, Hebei Weierkang. The case has drawn much attention from the public, because the results of the judgment will influence the overall exp...
Vitamins China E-News 201806